Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesSteven E. Lipshultz, Stephen E. Sallan, Suzanne E. Dahlberg et al.|PEDIATRICS|2012Cited by 176
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemiaSteven E. Lipshultz, Lewis B. Silverman, Stuart R. Lipsitz et al.|Cancer|2013Cited by 160